insights_auto
Why is GH down 2,23%?
Dive Deeperchevron_right
GH:NASDAQ
Guardant Health Inc
162,94 $
arrow_downward
-2,23%(-3,72) 1D
162,94 $
0,00% (0,00)
bedtimeAfter hours
Closed: 22 հոկ, 16:00:01 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GH...
Open
165,03 $
High
167,25 $
Low
158,68 $
Mkt. cap
21,87 մլրդ
Avg. vol.
1,83 մլն
Volume
1,77 մլն
52-wk high
191,01 $
52-wk low
66,59 $
EPS
-3,50 $
Beta
1,58
Shares outstanding
134,20 մլն
No. of employees
2 հզր
Open
165,03 $
High
167,25 $
Low
158,68 $
Mkt. cap
21,87 մլրդ
Avg. vol.
1,83 մլն
Volume
1,77 մլն
52-wk high
191,01 $
52-wk low
66,59 $
EPS
-3,50 $
Beta
1,58
Shares outstanding
134,20 մլն
No. of employees
2 հզր
News stories
From web sources and news partners
Investor's Business Daily
·
5 ժամ առաջ
The Stock Of The Day, And Its Rivals, Are Taking A Breather
News Corp
·
1 օր առաջ
7 healthcare stocks that stand out as investors pay up for the sector
Stocks Down Under
·
3 օր առաջ
Guardant Health (NDQ:GH): The Company Betting Its Cancer Screening Method Will Be Revolutionary!
Profile
Guardant Health, Inc. is an American biotechnology company based in Palo Alto, California. Co-founders Helmy Eltoukhy and AmirAli Talasaz serve as co-chief executive officers. Wikipedia
About Guardant Health Inc
CEOHelmy Eltoukhy | AmirAli Talasaz
Employees2,5 հզր
Founded2012
HeadquartersՊալո Ալտո, Կալիֆոռնիա, Միացյալ Նահանգներ
SectorHealth care provider
Websiteguardanthealth.com